Insights

Gathering insights about NKD…

Similar companies to NKD

NKD Tech Stack

NKD uses 8 technology products and services including Cookie Notice, Twemoji, jQuery Migrate, and more. Explore NKD's tech stack below.

Cookie Notice
Cookie Compliance
Twemoji
Font Scripts
jQuery Migrate
Javascript Libraries
jQuery UI
Javascript Libraries
Pardot
Marketing
Priority Hints
Performance
DHL
Transportation And Fleet Management
IONOS
Web Hosting

Media & News

MannKind Corporation (MNKD) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease Transcript
MannKind Corporation ( MNKD ) Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 10, 2025 9:00 AM EST Company Participants Michael Castagna - CEO & Director Conference Call Participants Olivia Brayer - Cantor Fitzgerald & Co., Research Division Benjamin Burnett - Wells Fargo Securities, LLC, Research Division Faisal Khurshid - Leerink Partners LLC, Research Division Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Presentation Operator Good morning, and welcome to MannKind Corporation's investor call to discuss a clinical trial update.
Nov 10, 2025 | seekingalpha.com
MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for nontuberculous mycobacterial (NTM) lung disease, following a futility determination based on medical monitoring data This outcome does not impact the development of MNKD-102, MannKind's dry powder inhalation (DPI) formulation of clofazimine, which remains under consideration for future clinical advancement MannKind extends its sincere gratitude to the study participants, investigators, advisors, and clinical site teams for their invaluable contributions to the ICoN-1 study MannKind will host a conference call today at 9:00 AM EST to discuss this update in more detail DANBURY, Conn. and WESTLAKE VILLAGE, Calif.
Nov 10, 2025 | www.globenewswire.com
MannKind Commemorates Alfred E. Mann's 100th Birthday with New Scholarship Program Supporting Young Adults Living with Diabetes
$100,000 in scholarship funds to be distributed to at least 10 students living with diabetes pursuing higher education in life sciences Alfred E. Mann Charities and MannKind are partnering with The Diabetes Link to launch the effort in November for Diabetes Awareness Month DANBURY, Conn.
Nov 06, 2025 | www.globenewswire.com
MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript
MannKind Corporation ( MNKD ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Michael Castagna - CEO & Director Christopher Prentiss - Chief Financial Officer Conference Call Participants Olivia Brayer - Cantor Fitzgerald & Co., Research Division Andreas Argyrides - Oppenheimer & Co. Inc., Research Division Yun Zhong - Wedbush Securities Inc., Research Division Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Presentation Operator " Michael Castagna CEO & Director " Christopher Prentiss Chief Financial Officer " Olivia Brayer Cantor Fitzgerald & Co., Research Division " Cantor Fitzgerald & Co., Research Division Unknown Analyst " Andreas Argyrides Oppenheimer & Co. Inc., Research Division " Oppenheimer & Co. Inc., Research Division Yun Zhong Wedbush Securities Inc., Research Division " Wedbush Securities Inc., Research Division Brandon Folkes H.C.
Nov 05, 2025 | seekingalpha.com
MannKind (MNKD) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for MannKind (MNKD) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nov 05, 2025 | www.zacks.com
MannKind (MNKD) Tops Q3 Earnings and Revenue Estimates
MannKind (MNKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago.
Nov 05, 2025 | www.zacks.com
MannKind Corporation Reports Third Quarter 2025 Financial Results and Provides Business Update
Q3 2025 revenues of $82.1M, +17% v. Q3 2024 YTD 2025 revenues of $237.0M, +14% v.
Nov 05, 2025 | www.globenewswire.com

NKD's Email Address Formats

NKD uses at least 1 format(s):

NKD Email Formats	Example	Percentage
First@nkd.co.uk	John@nkd.co.uk	73%
First.Last@nkd.co.uk	John.Doe@nkd.co.uk	15%
FirstLast@nkd.co.uk	JohnDoe@nkd.co.uk	9%
Last@nkd.co.uk	Doe@nkd.co.uk	3%

Frequently Asked Questions

Where is NKD's headquarters located?

NKD's main headquarters is located at NKD, Storey, 1 Finsbury Avenue, London, EC2M 2PF, GB. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is NKD's stock symbol?

NKD is a publicly traded company; the company's stock symbol is MNKD.

What is NKD's official website and social media links?

NKD's official website is nkd.co.uk and has social profiles on LinkedIn.

What is NKD's NAICS code?

NKD's NAICS code is 6114 - Business Schools and Computer and Management Training.

How many employees does NKD have currently?

As of October 2025, NKD has approximately 183 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: M. J. F.Chief Operating Officer: A. S.Chief Financial Officer: B. M.. Explore NKD's employee directory with LeadIQ.

What industry does NKD belong to?

NKD operates in the Professional Training and Coaching industry.

What technology does NKD use?

NKD's tech stack includes Cookie NoticeTwemojijQuery MigratejQuery UIPardotPriority HintsDHLIONOS.

What is NKD's email format?

NKD's email format typically follows the pattern of First@nkd.co.uk. Find more NKD email formats with LeadIQ.

When was NKD founded?

NKD was founded in 2005.

NKD

Professional Training and CoachingUnited Kingdom51-200 Employees

Hello… we’re NKD.

We work with businesses to activate cultural transformation through Learning and Skills Training and Leadership Development.

Together we shift thinking, 
change behaviour and transform performance.

To read more about our services, visit: https://nkd.co.uk/solutions/